| Fredun Pharmaceuticals Ltd Industry: (Pharmaceuticals - Indian - Formulations) |
|---|
|
BSE Code:
539730
ISIN Demat:
INE194R01017
Book Value(₹): 465.19 NSE Symbol: N.A Div & Yield(%):
0.02
Market Cap(₹ Cr): 1,394.08 P/E(TTM):
40.95
EPS(TTM):
61.76
Face Value(₹): 10.00 |
| Particulars | Dec 2025 (₹ Cr) | Sep 2025 (₹ Cr) | Jun 2025 (₹ Cr) |
|---|---|---|---|
| Gross Sales | 159.93 | 143.59 | 119.40 |
| Excise Duty | 0.00 | 0.00 | 0.00 |
| Net Sales | 159.93 | 143.59 | 119.40 |
| Other Operating Income | 1.00 | 1.71 | 0.45 |
| Other Income | 0.00 | 0.00 | 0.00 |
| Total Income | 160.92 | 145.29 | 119.86 |
| Total Expenditure | 134.59 | 122.96 | 102.86 |
| PBIDT | 26.34 | 22.34 | 16.99 |
| Interest | 10.55 | 7.73 | 6.53 |
| PBDT | 15.79 | 14.60 | 10.46 |
| Depreciation | 1.78 | 1.60 | 1.42 |
| Tax | 3.52 | 3.27 | 2.27 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 10.48 | 9.73 | 6.77 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 10.48 | 9.73 | 6.77 |
| EPS (Unit Curr.) | 22.19 | 20.61 | 14.33 |
| EPS (Adj) (Unit Curr.) | 22.19 | 20.61 | 14.33 |
| Calculated EPS (Unit Curr.) | 22.19 | 20.61 | 14.33 |
| Calculated EPS (Adj) (Unit Curr.) | 22.19 | 20.61 | 14.33 |
| Calculated EPS (Ann.) (Unit Curr.) | 88.77 | 82.45 | 57.32 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 88.77 | 82.45 | 57.32 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 |
| Equity | 4.72 | 4.72 | 4.72 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 2,411,277.00 | 2,411,277.00 | 2,411,277.00 |
| Public Shareholding (% in Equity) | 51.07 | 51.07 | 51.07 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 2,310,385.00 | 2,310,385.00 | 2,310,385.00 |
| Non Encumbered - % in Total Promoters Holding | 100.00 | 100.00 | 100.00 |
| Non Encumbered - % in Total Equity | 48.93 | 48.93 | 48.93 |
| PBIDTM(%) | 16.47 | 15.56 | 14.23 |
| PBDTM(%) | 9.87 | 10.17 | 8.76 |
| PATM(%) | 6.55 | 6.78 | 5.67 |
